These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16094155)

  • 1. Continuous intrathecal administration of 5-fluoro-2'-deoxyuridine for the treatment of neoplastic meningitis.
    Nakagawa H; Miyahara E; Suzuki T; Wada K; Tamura M; Fukushima Y
    Neurosurgery; 2005 Aug; 57(2):266-80; discussion 266-80. PubMed ID: 16094155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial of intrathecal administration of 5-fluoro-2'-deoxyuridine for treatment of meningeal dissemination of malignant tumors.
    Nakagawa H; Yamada M; Maeda N; Iwatsuki K; Hirayama A; Ikenaka K
    J Neurooncol; 1999; 45(2):175-83. PubMed ID: 10778733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal 5-fluoro-2'-deoxyuridine (FdUrd) for the treatment of solid tumor neoplastic meningitis: an in vivo study.
    Nakagawa H; Yamada M; Fukushima M; Ikenaka K
    Cancer Chemother Pharmacol; 1999; 43(3):247-56. PubMed ID: 9923556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical application of FdUrd to meningeal dissemination of malignant tumors].
    Nakagawa H; Yamada M; Maeda N; Iwatsuki K; Tsuzuki T; Hirayama A; Yamamoto H; Ikenaka K
    No Shinkei Geka; 1998 Nov; 26(11):969-77. PubMed ID: 9834491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro study on intrathecal use of 5-fluoro-2'-deoxyuridine (FdUrd) for meningeal dissemination of malignant brain tumors.
    Yamada M; Nakagawa H; Fukushima M; Shimizu K; Hayakawa T; Ikenaka K
    J Neurooncol; 1998 Apr; 37(2):115-21. PubMed ID: 9524089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vivo study on intrathecal use of 5-fluoro-2'-deoxyuridine (FdUrd) in meningeal dissemination of malignant tumor].
    Nakagawa H; Yamada M; Fukushima M; Shimizu K; Ikenaka K
    No Shinkei Geka; 1998 Oct; 26(10):873-9. PubMed ID: 9789291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracavitary chemotherapy with 5-fluoro-2'-deoxyuridine (FdUrd) in malignant brain tumors.
    Nakagawa H; Maeda N; Tsuzuki T; Suzuki T; Hirayama A; Miyahara E; Wada K
    Jpn J Clin Oncol; 2001 Jun; 31(6):251-8. PubMed ID: 11463802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience.
    Gaviani P; Corsini E; Salmaggi A; Lamperti E; Botturi A; Erbetta A; Milanesi I; Legnani F; Pollo B; Silvani A
    Neurol Sci; 2013 Dec; 34(12):2151-7. PubMed ID: 23525755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro study on intrathecal application of 5-fluoro-2'-deoxyuridine (FdUrd) for meningeal dissemination of malignant tumor].
    Nakagawa H; Yamada M; Fukushima M; Shimizu K; Ikenaka K
    No Shinkei Geka; 1998 Sep; 26(9):787-94. PubMed ID: 9757455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal administration of Y-27632, a specific rho-associated kinase inhibitor, for rat neoplastic meningitis.
    Nakagawa H; Yoshioka K; Miyahara E; Fukushima Y; Tamura M; Itoh K
    Mol Cancer Res; 2005 Aug; 3(8):425-33. PubMed ID: 16123138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoplastic meningitis from breast cancer: feasibility and activity of long-term intrathecal liposomal Ara-C combined with dose-dense temozolomide.
    Hoffmann AL; Buhk JH; Strik H
    Anticancer Res; 2009 Dec; 29(12):5191-5. PubMed ID: 20044635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
    Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
    Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of long-term intraventricular therapy with mafosfamide (n = 26) and etoposide (n = 11): experience in 26 children with disseminated malignant brain tumors.
    Slavc I; Schuller E; Falger J; Günes M; Pillwein K; Czech T; Dietrich W; Rössler K; Dieckmann K; Prayer D; Hainfellner J
    J Neurooncol; 2003 Sep; 64(3):239-47. PubMed ID: 14558599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal Fluid Dissemination and Neoplastic Meningitis in Primary Brain Tumors.
    Chowdhary S; Damlo S; Chamberlain MC
    Cancer Control; 2017 Jan; 24(1):S1-S16. PubMed ID: 28557973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
    Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
    Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of fluoropyrimidine Schedule and (6R,S)leucovorin dose in a preclinical animal model of colorectal carcinoma.
    Cao S; Frank C; Rustum YM
    J Natl Cancer Inst; 1996 Apr; 88(7):430-6. PubMed ID: 8618234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregional administration of 5-fluoro-2'-deoxyuridine (FdUrd) in Novikoff hepatoma in the rat: effects of dose and infusion time on tumor growth and on FdUrd metabolite levels in tumor tissue as determined by 19F-NMR spectroscopy.
    Naser-Hijazi B; Berger MR; Schmähl D; Schlag P; Hull WE
    J Cancer Res Clin Oncol; 1991; 117(4):295-304. PubMed ID: 1829730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
    Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis: a Pediatric Brain Tumor Consortium Study (PBTC-004).
    Gururangan S; Petros WP; Poussaint TY; Hancock ML; Phillips PC; Friedman HS; Bomgaars L; Blaney SM; Kun LE; Boyett JM
    Clin Cancer Res; 2006 Mar; 12(5):1540-6. PubMed ID: 16533779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current treatment approaches for neoplastic meningitis: nursing management of patients receiving intrathecal DepoCyt.
    Craig C
    Oncol Nurs Forum; 2000 Sep; 27(8):1225-30; quiz 1231-2. PubMed ID: 11013903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.